Hansa Biopharma AB HNSA
OMXSTO · Sweden · Health Technology
SEK 34.12+0.62 (+1.85%)
Market closed· · SEK · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · SEK · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-07-22 | -2.56 | -0.34 | -659.6% | SEK 48.10M | -4.5% | -8.0%SEK 33.38→SEK 30.70 |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.